Drug intelligence / Profile preview

Cortex Mori Radicis extract

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Cortex Mori Radicis extract (CMR) is a natural product derived from the root bark of various *Morus* species, including *Morus alba* (white mulberry). Traditionally utilized in Oriental medicine for the treatment of respiratory and metabolic conditions such as cough, edema, and diabetes, CMR is currently being investigated in preclinical research for its anti-inflammatory, anti-allergic, and neuroprotective properties. Its pharmacological profile involves the modulation of several intracellular signaling pathways, including the activation of the PI3K/AKT and ERK pathways and the upregulation of TRPC1 channels. In experimental models of asthma, CMR has demonstrated the ability to enhance the population of CD4+CD25+Foxp3+ regulatory T cells and suppress the production of Th2 cytokines, including IL-4, IL-5, and IL-13. Furthermore, it exhibits cardioprotective effects in diabetic models by mitigating endoplasmic reticulum stress and promotes neurite outgrowth, suggesting potential utility in neurodegenerative diseases and diabetic complications.

Other names
Mori CortexSang-Bai-Piroot bark of Morus albaMorus alba root bark extractCortex Mori
02

Targets

MAPK3 (Mitogen-activated protein kinase 1)MicrotubuleInterleukin-4, Interleukin-5, and Interleukin-13 signaling pathway

Beyond the preview

Go deeper on Cortex Mori Radicis extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cortex Mori Radicis extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call